MED28
Mediator of RNA polymerase II transcription subunit 28
Also known as: DKFZP434N185, EG1, magicin, MED28_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H204
- Gene
- MED28
- Ensembl
- ENSG00000118579
- Chromosome
- 4
- Canonical length
- 178 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable actin binding activity. Predicted to be involved in RNA polymerase II preinitiation complex assembly; positive regulation of transcription elongation by RNA polymerase II; and positive regulation of transcription initiation by RNA polymerase II. Predicted to act upstream of or within negative regulation of smooth muscle cell differentiation and somatic stem cell population maintenance. Located in nucleoplasm. Part of core mediator complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
178 residues, UniProt reviewed canonical sequence.
>Q9H204|MED28
1 MAAPLGGMFS GQPPGPPQAP PGLPGQASLL QAAPGAPRPS SSTLVDELES SFEACFASLV
61 SQDYVNGTDQ EEIRTGVDQC IQKFLDIARQ TECFFLQKRL QLSVQKPEQV IKEDVSELRN
121 ELQRKDALVQ KHLTKLRHWQ QVLEDINVQH KKPADIPQGS LAYLEQASAN IPAPLKPTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MED28 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- ovary: 14 nTPM
- skeletal muscle: 12 nTPM
- cervix: 12 nTPM
- bone marrow: 12 nTPM
- endometrium: 11 nTPM
- cerebellum: 11 nTPM
Single-cell type
- extravillous trophoblasts: 203 nCPM
- migrating cytotrophoblasts: 172 nCPM
- syncytiotrophoblasts: 146 nCPM
- esophageal apical cells: 139 nCPM
- cytotrophoblasts: 131 nCPM
- hofbauer cells: 123 nCPM
Immune cell
- neutrophil: 8.9 nTPM
- total PBMC: 7.4 nTPM
- classical monocyte: 6.6 nTPM
- eosinophil: 6.5 nTPM
- myeloid DC: 6.4 nTPM
- naive CD4 T-cell: 6.4 nTPM
Brain region
- white matter: 30 nTPM
- medulla oblongata: 26 nTPM
- hypothalamus: 26 nTPM
- thalamus: 26 nTPM
- cerebellum: 25 nTPM
- basal ganglia: 25 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.4
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.28
- DepMap mean gene effect
- -1.24
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of smooth muscle cell differentiation
- positive regulation of transcription elongation by RNA polymerase II
- positive regulation of transcription initiation by RNA polymerase II
- RNA polymerase II preinitiation complex assembly
- somatic stem cell population maintenance
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Mediator complex, subunit Med28
- Mediator complex subunit 28
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MED28 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MED28 as an antibody target. Whether an autoantibody or antibody against MED28 could matter depends on whether native MED28 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MED28 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MED28 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...